Imbio PHA (4.0.0) vs OMRON VitalSight
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your clinical practice requires rapid, AI-powered analysis of CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation. This tool is ideal for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing automated, precise measurements of cardiac structures and ratios directly from imaging data.
View Imbio PHA (4.0.0) →Choose OMRON VitalSight if…
Choose OMRON VitalSight if you need a robust remote patient monitoring solution to manage hypertension for your patient population. This service is best suited for physicians looking to securely integrate at-home blood pressure readings into EHRs, enabling continuous oversight and proactive intervention for out-of-range readings, even for patients without home internet access.
View OMRON VitalSight →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | OMRON VitalSight |
|---|---|---|
| Pricing | Unknown | Reimbursement-based |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud-based (physician dashboard) with at-home patient devices. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA excels in clinician usability by seamlessly integrating into existing radiology DICOM workflows, providing rapid, automated analysis without adding extra steps. Its minimal user interface ensures that radiologists can effortlessly incorporate the AI-driven insights into their diagnostic process. While OMRON VitalSight prioritizes patient ease of use, Imbio's deep integration into professional clinical workflows gives it an edge for the primary healthcare professional user.
Clinical Value
OMRON VitalSightOMRON VitalSight demonstrates superior clinical value through its proven impact on patient outcomes, showing greater blood pressure control and lower systolic blood pressure in hypertension patients over 12 months in clinical studies. While Imbio PHA provides accurate diagnostic and risk stratification data for acute conditions, VitalSight's direct evidence of improving chronic disease management and patient health metrics gives it a slight advantage in demonstrated clinical impact.
Pricing & Value
OMRON VitalSightOMRON VitalSight clearly wins this dimension due to its transparent, reimbursement-based pricing model, which explicitly states little to no cost for patients and no setup or device costs for physicians. This financial accessibility and clear path to revenue generation for providers offer a strong value proposition. Imbio PHA, by contrast, requires direct contact for pricing, making its value proposition less transparent and immediately assessable.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA offers superior enterprise readiness with flexible deployment options, including both cloud and on-premise solutions, catering to a wider range of institutional IT and security requirements. Its deep integration with native DICOM tools and workflows is crucial for large imaging departments. While OMRON VitalSight offers EHR integration and cloud-based deployment, Imbio's broader deployment flexibility provides a more robust solution for diverse enterprise environments.
Innovation
Imbio PHA (4.0.0)Imbio PHA demonstrates a higher degree of technological innovation by applying advanced AI algorithms to automate complex, quantitative analysis of medical images, transforming diagnostic workflows and providing objective data for critical conditions. While OMRON VitalSight offers innovative features in remote patient monitoring, such as simplified patient experience and seamless data transfer without Wi-Fi, Imbio's AI-driven image analysis represents a more cutting-edge application of AI in healthcare.
Support & Docs
OMRON VitalSightOMRON VitalSight provides a slightly more comprehensive and readily available range of support resources, including user manuals, FAQs, and clear guidance on warranty and service centers, which is particularly important for a device-based service. Imbio PHA also offers user manuals and email support, but OMRON's broader array of easily accessible support documentation gives it an edge.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | OMRON VitalSight |
|---|---|---|
| Product Name | Imbio PHA (4.0.0) | OMRON VitalSight |
| Company | Imbio | OMRON Healthcare |
| Primary Function | AI-powered medical image processing software for automated cardiac structure measurement from CTPA scans to assess right ventricular dilation and aid in PE/HTN diagnosis and risk stratification. | Remote patient monitoring service with connected blood pressure monitors and data hubs for hypertension management and improved patient outcomes. |
| Key Outputs/Data | Automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, RV/LV and PA/Ao ratios; annotated DICOM images; PDF summary reports. | Remote blood pressure monitoring data; automatic notifications for out-of-range readings; EHR/EMR integration or VitalSight Dashboard access. |
| Target Medical Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Internal Medicine, Nephrology |
| Core Technology | AI-powered medical image processing software | Connected blood pressure monitors and data hubs for remote patient monitoring |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and OMRON VitalSight.